Combination of doses, better than monotherapy for pulmonary hypertension

Published Date: 08 Mar 2023

People with hypertension (high blood pressure in the arteries that supply the lungs, also known as PAH) have up to a two-fold reduction in pulmonary vascular resistance (PVR) when taking PAH.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety

2.

Drugmaker Pulls Trodelvy's Bladder Cancer Approval

3.

Patients face high out-of-pocket costs after incident cancer diagnosis

4.

Childhood cancer survivors face new health problems later in life, study shows

5.

Mutation Clearance After Transplant Linked to Better Outcomes in Myelofibrosis


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot